Updated Insights on Levetiracetam-Associated Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis

Background Previous studies have explored the association between levetiracetam (LEV) and severe cutaneous adverse reactions (SCARs). However, most investigations have relied on clinical trial data or case reports from individual medical centers. Consequently, the precise relationship between LEV and SCARs in real-world settings remains elusive.